ArticleEuropean physical journal plus2023
The Swiss Light Source and SwissFEL at the Paul Scherrer Institute.
Article in European physical journal plus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Dichography: two-frame ultrafast imaging from a single diffraction pattern.Nature communications · 2026Article
- Fast Small-Angle X-Ray Scattering Tensor Tomography: An Outlook into Future Applications in Life Sciences.Small methods · 2026Article
- Evolution of macromolecular crystallography beamlines at the Swiss Light Source and SwissFEL.Journal of synchrotron radiation · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
At the Paul Scherrer Institute, two electron accelerator-based photon sources are in operation, namely a synchrotron source, the swiss light source (SLS), and an X-ray free-electron laser, SwissFEL. SLS has been operational since 2001 and SwissFEL since 2017. In this time, unique and world-leading scientific programs and methods have developed from the SLS and the SwissFEL in fields as diverse as macromolecular biology, chemical and physical sciences, imaging, and the electronic structure and behaviour of novel and complex materials. To continue the success, a major upgrade of SLS, the SLS2.0 project, is ongoing and at SwissFEL further endstations are under construction.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.